abstract |
The present invention relates to a novel 4-piperazinylpyrimidine compound. The compound has useful therapeutic properties, particularly is suitable in treating diseases that respond to modulation of the dopamine D 3 receptor. The 4-piperazinylpyrimidine compound has the general formula (I), where Ar, X, A, R 1 and R 1a are as defined in the claims. |